{"database": "press", "table": "releases", "rows": [["https://buddycarter.house.gov/news/documentsingle.aspx?DocumentID=11517", "White House heeds Carter\u2019s warning to increase American-made medicines and reduce drug shortages", "2023-11-28", "2023", "2023-11", "Republican", "House", "GA", "Earl L. \"Buddy\" Carter", "C001103", "buddycarter.house.gov", "buddycarter", "https://buddycarter.house.gov/news/documentquery.aspx?DocumentTypeID=27", "scraper", "WASHINGTON, D.C. \u2013 The White House announced new actions to strengthen America\u2019s pharmaceutical supply chains and address prescription drug shortages following Rep. Earl L. \u201cBuddy\u201d Carter\u2019s (R-GA) leadership on these issues as a pharmacist by trade and Chair of the Domestic Pharmaceutical Manufacturing Caucus.\n\nCurrently, the U.S. is experiencing a shortage of over 240 essential medications, leaving many states without necessary resources to provide for their citizens\u2019 health and safety. This is due, in part, to the United States\u2019 dependence on China and other foreign adversaries for pharmaceuticals. Chinese imports to the U.S. now account for 95 percent of ibuprofen, 91 percent of hydrocortisone, 70 percent of acetaminophen, and 40 to 45 percent of penicillin.\n\n\u201cAs a pharmacist, ensuring that life-saving medications are accessible, available, and affordable has been one of my top priorities in Congress. I\u2019m glad that the White House has paid attention to this bipartisan effort and is working towards building a more resilient domestic pharmaceutical supply chain and stockpiling essential medications on both the national and state levels,\u201d said Rep. Carter. \u201cWe have a lot more work to do, including passing my MADE in America Act, but this is a positive step that will bring relief to Americans and our health care system.\u201d\n\nPulling from Rep. Carter\u2019s landmark and bipartisan Manufacturing API, Drugs, and Excipients (MADE) in America Act, State Strategic Stockpile Act, and Essential Medicine Strategic Stockpile Act, the White House\u2019s plan will:\n\nUse the Defense Production Act to make more essential medicines in America and mitigate drug shortages;\n\nEstablish a White House Council on Supply Chain Resilience; and,\n\nEstablish the Global Regulatory Working Group on Drug Shortages.\n\nRead more about the White House\u2019s plan here.\n\nClick to read full text of Rep. Carter\u2019s MADE in America Act, State Strategic Stockpile Act, and Essential Medicine Strategic Stockpile Act.", 1, "2026-03-30T01:40:41Z", "2026-04-08T01:01:09Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://buddycarter.house.gov/news/documentsingle.aspx?DocumentID=11517"], "units": {}, "query_ms": 1.0594159830361605, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}